OBJECTIVES: To determine the prevalence and interrelation of cervical human papillomavirus (HPV) genotypes, squamous intraepithelial lesions (SIL), HIV, and other reproductive tract infections (RTIs) among urban antenatal clinic attenders in Mwanza, Tanzania. METHODS: Genital swabs were collected from 660 pregnant women and tested for a range of RTIs and for cervical cytology. Cervical HPV-DNA was detected by PCR and genotyped. HIV and syphilis serologies were performed. RESULTS: HPV prevalence was 34% (209/612 women). Of the 144 typeable samples, 83% were high risk (HR-HPV) oncogenic strains (56% HPV 16 related types). SIL was detected in 43 women (7%), with high grade SIL in 3%. There was a high prevalence of HIV (15%), and of any RTI (83%). Genital warts were detected in 20 women (3%). HPV infection was associated with some behavioural factors (short duration of relationship, single status, not using condoms) and gonorrhoea. There was no overall association between HPV and HIV (OR=1.02, 95% CI 0.6-1.6), but a non-significant trend towards a stronger association with HR-HPV in women aged 15-19 (OR=2.79, 95% CI 0.8-9.5) and women aged > or =30 (OR=3.20, 95% CI 0.7-15). SIL was associated with HPV (OR=3.66, 95% CI 1.9-7.0), but not significantly with HIV (OR=1.54, 95% CI 0.7-3.4). Prevalence of SIL was higher among women dually positive for HPV/HIV compared to HPV infection only (21% v 12%), although this difference was not statistically significant (p=0.17). CONCLUSIONS: HPV infection was highly prevalent in this young antenatal population. The association of HIV with HR-HPV types in older women may suggest that the principal HIV/HPV interaction in this population is for HIV to upregulate HPV persistence, leading to subsequent development of SIL.
OBJECTIVES: To determine the prevalence and interrelation of cervical human papillomavirus (HPV) genotypes, squamous intraepithelial lesions (SIL), HIV, and other reproductive tract infections (RTIs) among urban antenatal clinic attenders in Mwanza, Tanzania. METHODS: Genital swabs were collected from 660 pregnant women and tested for a range of RTIs and for cervical cytology. Cervical HPV-DNA was detected by PCR and genotyped. HIV and syphilis serologies were performed. RESULTS:HPV prevalence was 34% (209/612 women). Of the 144 typeable samples, 83% were high risk (HR-HPV) oncogenic strains (56% HPV 16 related types). SIL was detected in 43 women (7%), with high grade SIL in 3%. There was a high prevalence of HIV (15%), and of any RTI (83%). Genital warts were detected in 20 women (3%). HPV infection was associated with some behavioural factors (short duration of relationship, single status, not using condoms) and gonorrhoea. There was no overall association between HPV and HIV (OR=1.02, 95% CI 0.6-1.6), but a non-significant trend towards a stronger association with HR-HPV in women aged 15-19 (OR=2.79, 95% CI 0.8-9.5) and women aged > or =30 (OR=3.20, 95% CI 0.7-15). SIL was associated with HPV (OR=3.66, 95% CI 1.9-7.0), but not significantly with HIV (OR=1.54, 95% CI 0.7-3.4). Prevalence of SIL was higher among women dually positive for HPV/HIV compared to HPV infection only (21% v 12%), although this difference was not statistically significant (p=0.17). CONCLUSIONS:HPV infection was highly prevalent in this young antenatal population. The association of HIV with HR-HPV types in older women may suggest that the principal HIV/HPV interaction in this population is for HIV to upregulate HPV persistence, leading to subsequent development of SIL.
Authors: C L Langley; E Benga-De; C W Critchlow; I Ndoye; M D Mbengue-Ly; J Kuypers; G Woto-Gaye; S Mboup; C Bergeron; K K Holmes; N B Kiviat Journal: AIDS Date: 1996-04 Impact factor: 4.177
Authors: D Serwadda; M J Wawer; K V Shah; N K Sewankambo; R Daniel; C Li; A Lorincz; M P Meehan; F Wabwire-Mangen; R H Gray Journal: J Infect Dis Date: 1999-10 Impact factor: 5.226
Authors: S D Vernon; W C Reeves; K A Clancy; M Laga; M St Louis; H E Gary; R W Ryder; A T Manoka; J P Icenogle Journal: J Infect Dis Date: 1994-05 Impact factor: 5.226
Authors: P G Motti; G A Dallabetta; R W Daniel; J K Canner; J D Chiphangwi; G N Liomba; L Yang; K V Shah Journal: J Infect Dis Date: 1996-03 Impact factor: 5.226
Authors: J ter Meulen; H C Eberhardt; J Luande; H N Mgaya; J Chang-Claude; H Mtiro; M Mhina; P Kashaija; S Ockert; X Yu Journal: Int J Cancer Date: 1992-06-19 Impact factor: 7.396
Authors: A C Seck; M A Faye; C W Critchlow; A D Mbaye; J Kuypers; G Woto-Gaye; C Langley; E B De; K K Holmes; N B Kiviat Journal: Int J STD AIDS Date: 1994 May-Jun Impact factor: 1.359
Authors: M Urassa; Y Kumogola; R Isingo; G Mwaluko; B Makelemo; K Mugeye; T Boerma; T Calleja; E Slaymaker; B Zaba Journal: Sex Transm Infect Date: 2006-08 Impact factor: 3.519
Authors: Frank Tanser; Kyle G Jones; Johannes Viljoen; John Imrie; Erofili Grapsa; Marie-Louise Newell Journal: Sex Transm Dis Date: 2013-07 Impact factor: 2.830